Raymond James Financial Services Advisors’s Tvardi Therapeutics, Inc. Common Stock TVRD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-283
| Closed | -$124K | – | 3352 |
|
|
2022
Q1 | $124K | Sell |
283
-24
| -8% | -$10.5K | ﹤0.01% | 3059 |
|
|
2021
Q4 | $135K | Sell |
307
-1
| -0.3% | -$440 | ﹤0.01% | 3063 |
|
|
2021
Q3 | $171K | Buy |
308
+3
| +1% | +$1.67K | ﹤0.01% | 3020 |
|
|
2021
Q2 | $157K | Sell |
305
-12
| -4% | -$6.18K | ﹤0.01% | 3060 |
|
|
2021
Q1 | $247K | Sell |
317
-2
| -0.6% | -$1.56K | ﹤0.01% | 2758 |
|
|
2020
Q4 | $174K | Sell |
319
-21
| -6% | -$11.5K | ﹤0.01% | 2758 |
|
|
2020
Q3 | $156K | Buy |
340
+4
| +1% | +$1.84K | ﹤0.01% | 2593 |
|
|
2020
Q2 | $207K | Buy |
336
+12
| +4% | +$7.39K | ﹤0.01% | 2465 |
|
|
2020
Q1 | $154K | Buy |
+324
| New | +$154K | ﹤0.01% | 2137 |
|